Log in or Sign up for Free to view tailored content for your specialty!
Addiction News
Cannabis, hallucinogen use ‘historically high’ among adults in 2023
Among young adults aged 19 to 30 years and early midlife adults aged 35 to 50 years, past-year use of cannabis and hallucinogens remained at “historically high” levels in 2023, according to the Monitoring the Future Panel Study Annual Report.
Vaping strongly correlates with cognitive function in young adults
ORLANDO, Fla. — In a cohort of South American young adults, those who smoked or vaped recorded lower scores on a cognitive assessment vs. those who did not, with a stronger correlation found between vapers and lower cognitive scores, data show.
White House strengthens legislation on equal access to mental health, substance use care
The White House moved to strengthen the Mental Health Parity and Addiction Equality Act to ensure individuals with private insurance have the same access to mental health services as they do for physical health services.
Log in or Sign up for Free to view tailored content for your specialty!
FDA finalizes new age restrictions on sale of tobacco products
The U.S. Food and Drug Administration published a final rule raising the age of certain restrictions on the sale of tobacco products, according to an agency press release.
Important updates for International Overdose Awareness Day
Aug. 31 is International Overdose Awareness Day. It is a time to remember those lost to substance use disorders and addiction, particularly as the United States and countries around the globe grapple with the opioid crisis.
VIDEO: Case-based collaborative learning useful in psychoeducation
NEW YORK — In this Healio Video Perspective, Hyun Jung Kim, MD, discusses the format of her presentation on the relationship between cannabis use and risk for psychosis at the American Psychiatric Association Annual Meeting.
Current, prior substance use tied to hot flashes, other bothersome menopause symptoms
Current and prior heavy alcohol, tobacco, marijuana or opioid use were all independently associated with vasomotor, mood or musculoskeletal symptoms experienced during menopause, researchers reported.
FDA’s MDMA ruling raises the bar for psychedelic research
There are two FDA-approved medications for PTSD, both selective serotonin reuptake inhibitors. The FDA has not approved a new medication for PTSD since 2001.
Healio wins APEX award for Psychedelics & Alternative Therapies collection
The Healio news staff received an APEX award in the category of Writing/Topics for work on the potential role of psychedelics and alternative therapies for mental health issues and other medical conditions.
Attention to lifestyle the cornerstone to maintaining and improving mental health
NEW YORK — Paying attention to one’s lifestyle is a cornerstone to maintaining and improving both physical and mental health, according to the new president of the American Psychiatric Association.
-
Headline News
‘The mind is medicine’: How virtual reality can cool bothersome hot flashes
September 18, 20244 min read -
Headline News
CDC: Close contact of Missouri bird flu case had symptoms but was not tested
September 17, 20242 min read -
Headline News
Metformin use may lower risk for long COVID in adults with type 2 diabetes
September 18, 20243 min read
-
Headline News
‘The mind is medicine’: How virtual reality can cool bothersome hot flashes
September 18, 20244 min read -
Headline News
CDC: Close contact of Missouri bird flu case had symptoms but was not tested
September 17, 20242 min read -
Headline News
Metformin use may lower risk for long COVID in adults with type 2 diabetes
September 18, 20243 min read